Connect Biopharma Holdings Limited (NASDAQ: CNTB)
$1.28
+0.0200 ( +1.59% ) 72.8K
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Market Data
Open
$1.28
Previous close
$1.26
Volume
72.8K
Market cap
$69.98M
Day range
$1.25 - $1.34
52 week range
$0.53 - $2.84
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 4 | Jun 12, 2024 |
20-f | Annual reports | 162 | Apr 16, 2024 |
6-k | Quarterly Reports | 3 | Apr 16, 2024 |
6-k | Quarterly Reports | 1 | Feb 12, 2024 |
6-k | Quarterly Reports | 3 | Dec 12, 2023 |
6-k | Quarterly Reports | 8 | Nov 21, 2023 |
6-k | Quarterly Reports | 1 | Nov 01, 2023 |
6-k | Quarterly Reports | 1 | Oct 20, 2023 |
6-k | Quarterly Reports | 110 | Sep 12, 2023 |
6-k | Quarterly Reports | 1 | Sep 12, 2023 |